C reactive protein concentration and recurrence of atrial fibrillation after electrical cardioversion.
about
Lipid-lowering drug use is associated with reduced prevalence of atrial fibrillation in patients with left ventricular systolic dysfunction.Predictors of atrial fibrillation recurrence after cryoballoon ablation.Risk of Atrial Fibrillation or Flutter Associated with Periodontitis: A Nationwide, Population-Based, Cohort Study.Clinical use of and future perspectives on antiarrhythmic drugs.C-Reactive Protein and The Risk of Atrial Fibrillation: A Systematic Review and Meta-AnalysisValue of high-sensitivity C-reactive protein assays in predicting atrial fibrillation recurrence: a systematic review and meta-analysis.Atrial fibrillation and inflammation.The role of F18-fluorodeoxyglucose positron emission tomography in identifying patients at high risk for lethal arrhythmias from cardiac sarcoidosis and the use of serial scanning to guide therapy.Normalization of Testosterone Levels After Testosterone Replacement Therapy Is Associated With Decreased Incidence of Atrial FibrillationA functional variant in the promoter region regulates the C-reactive protein gene and is a potential candidate for increased risk of atrial fibrillation.Is Helicobacter pylori a cause of atrial fibrillation?The efficacy of radiofrequency ablation in the treatment of pediatric arrhythmia and its effects on serum IL-6 and hs-CRP.Plasma profiles of matrix metalloproteinases and tissue inhibitors of the metalloproteinases predict recurrence of atrial fibrillation following cardioversion.Discordant regulation of CRP and NT-proBNP plasma levels after electrical cardioversion of persistent atrial fibrillation.NT-proBNP, but not ANP and C-reactive protein, is predictive of paroxysmal atrial fibrillation in patients undergoing pulmonary vein isolation.The relevance of the association between inflammation and atrial fibrillation
P2860
Q35187745-1E0BBA4F-B1DB-4018-99AC-43BA272DE738Q35821956-DE581315-7139-4385-AD26-A91BBC86E3FAQ36178661-D30BB295-8865-4318-9549-A519787F8196Q37002176-2A642916-B7FB-45F5-A4AE-3CEEDD7B944AQ37115344-9E03B1B3-2CF8-49AE-8BC6-2100D1C9D295Q37598033-A3122C55-B47F-41AF-B62C-D08D0F465D13Q37821236-29FFF4BF-E0BC-460D-A40D-F8E105709433Q38167672-F08572E5-D61C-4C58-902F-AA123C5A10F5Q38795260-D165B407-657C-40CD-B05D-FE2E8C647515Q39653047-121F261B-A8F3-4724-AA73-D4446E8A6912Q40311508-26773F0E-EEA0-4338-A77F-6D62DBE660DFQ42376409-E90CC1AD-1394-4EEA-B5F6-97523834B296Q45840647-4BAFDC23-6138-4B1D-91C5-B9508BCF1EE6Q48493268-1044375B-1E61-49AA-90A9-4B622C7EB3E6Q48884071-C1A1A75F-7CDD-4302-B800-2A6A4782A2B8Q57235780-EBC0B9E8-2C83-4FCD-B9EF-550355BD9C2B
P2860
C reactive protein concentration and recurrence of atrial fibrillation after electrical cardioversion.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
C reactive protein concentrati ...... fter electrical cardioversion.
@ast
C reactive protein concentrati ...... fter electrical cardioversion.
@en
type
label
C reactive protein concentrati ...... fter electrical cardioversion.
@ast
C reactive protein concentrati ...... fter electrical cardioversion.
@en
prefLabel
C reactive protein concentrati ...... fter electrical cardioversion.
@ast
C reactive protein concentrati ...... fter electrical cardioversion.
@en
P2093
P2860
P356
P1433
P1476
C reactive protein concentrati ...... fter electrical cardioversion.
@en
P2093
D O Martin
M Shaaraoui
N F Marrouche
R A Schweikert
S Almahameed
W I Saliba
P2860
P304
P356
10.1136/HRT.2004.038661
P407
P577
2005-05-12T00:00:00Z